Genetic Technologies Limited
Save
5.97M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons.
Similar securities
Based on sector and market capitalization
Report issue